Yanrong Hao

机构：State Key Laboratory of Plant Genomics, The People's Hospital of Guangxi Zhuang Autonomous Region, University of Chinese Academy of Sciences · ORCID：0000-0002-2265-0800

发表论文 57 篇 · 总被引 1145 次 · h-index 16

代表论文

• Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer (2022 · JAMA · 被引 473)
• Depression, anxiety and post-traumatic growth among COVID-19 survivors six-month after discharge (2022 · European Journal of Psychotraumatology · 被引 62)
• First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors (2023 · Journal of Hematology & Oncology · 被引 57)
• Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours (2023 · npj Breast Cancer · 被引 55)
• Associations between COVID-19 related stigma and sleep quality among COVID-19 survivors six months after hospital discharge (2021 · Sleep Medicine · 被引 38)
• Post-traumatic Stress Disorder Symptoms in COVID-19 Survivors 6 Months After Hospital Discharge: An Application of the Conservation of Resource Theory (2022 · Frontiers in Psychiatry · 被引 30)